Skip to main content

Theodore S Lawrence

NIH Rank #4989
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1863924Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Radiology
  • Biomedical Engineering

NIH Funding · FY2024

Linked Award Amount
$2.1M
Full award amounts, FY2024
Award Records
6
Records listing this PI
Award-Linked Rank
#4,989
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Theodore S Lawrence. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Theodore S Lawrence as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA276217-02R01
    Ablating Liver Metastases with SBRT to Enhance Immune Checkpoint Blockade in Melanoma
    $542.3K
    award amount
  • 5R01CA271369-03R01
    Targeting Stromal Influences on BCKA Addiction in PDAC Tumors
    $534.2K
    award amount
  • 5R01CA248310-05R01
    Development of a first-in-class mEGFR dimerization inhibitor
    $398.3K
    award amount
  • 3R01CA248310-05S1R01
    Development of a first-in-class mEGFR dimerization inhibitor
    $351K
    award amount
  • 5P30CA046592-35P30
    University of Michigan Rogel Cancer Center Support Grant 2023-2028
    $161.8K
    award amount
  • 5P50CA269022-02P50
    Molecularly Targeted Radiosensitization of Locally Advanced Cancers
    $90.1K
    award amount

Award organization

Organizations that administered FY2024 awards listing Theodore S Lawrence as a PI.

FY2024 award administered by University of Michigan (MI).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Michigan
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4989
  6. 2024
    Entered Top 25% Nationally
    Ranked #4989
  7. 2025
    R01 Grant Holder
  8. 2025
    Program/Center Grant Leader